AGPAT2 antibody (C-Term)
Quick Overview for AGPAT2 antibody (C-Term) (ABIN205054)
Target
See all AGPAT2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- C-Term
-
Specificity
- Human AGPAT2
-
Predicted Reactivity
- Percent identity by BLAST analysis: Human (100%).
-
Purification
- Protein A purified
-
Immunogen
-
Synthetic peptide from C-Terminus of human AGPAT2 (Q5VUD3, NP_001012745). Percent identity by BLAST analysis: Human, Gorilla (100%), Monkey (92%).
Type of Immunogen: Synthetic peptide -
Isotype
- IgG
-
-
-
-
Application Notes
- Approved: WB (5 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- After adding water, will consist of PBS buffer with 2 % sucrose
-
Concentration
- Lot specific
-
Buffer
- Lyophilized from PBS with 2 % sucrose
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Long term: -20°C, the use of 50% glycerol is recommended if storing aliquots in -20°C for long term use (up to 1 year)
Short term (less than 1 week): 4°C. Avoid freeze-thaw cycles.
-
-
- AGPAT2 (1-Acylglycerol-3-Phosphate O-Acyltransferase 2 (Lysophosphatidic Acid Acyltransferase, Beta) (AGPAT2))
-
Alternative Name
- AGPAT2
-
Background
-
Name/Gene ID: AGPAT2
Synonyms: AGPAT2, 1-AGPAT2, 1-AGPAT 2, 1-AGP acyltransferase 2, BSCL, BSCL1, LPAAB, LPAAT-beta -
Gene ID
- 10555
-
NCBI Accession
- NP_001012745
-
UniProt
- O15120
Target
-